Neurophysiological predictors of non-response to rTMS in depression
暂无分享,去创建一个
J. Leon Kenemans | Paul B. Fitzgerald | Martijn Arns | J. Kenemans | M. Arns | P. Fitzgerald | W. Drinkenburg | Wilhelmus H. Drinkenburg
[1] Robert B. Lufkin,et al. Cordance: A New Method for Assessment of Cerebral Perfusion and Metabolism Using Quantitative Electroencephalography , 1994, NeuroImage.
[2] B. Langguth,et al. Pre-treatment anterior cingulate activity as a predictor of antidepressant response to repetitive transcranial magnetic stimulation (rTMS). , 2007, Neuro endocrinology letters.
[3] G. Alexopoulos,et al. Prefrontal dysfunction and treatment response in geriatric depression. , 1999, Archives of general psychiatry.
[4] Rakesh Jain,et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: Results of the BRITE-MD study , 2009, Psychiatry Research.
[5] 行正 徹. High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors , 2007 .
[6] M. Arns,et al. Long Term Effects of Left Frontal rTMS on EEG and ERPs in Patients with Depression , 2008, Clinical EEG and neuroscience.
[7] P. Schoenknecht,et al. Hyperstable regulation of vigilance in patients with major depressive disorder , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[8] A. Conca,et al. Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add‐on therapy in severely depressed patients under SSRI treatment , 2000, Human psychopharmacology.
[9] S. Potkin,et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. , 2005, Schizophrenia bulletin.
[10] Sarah H Lisanby,et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. , 2010, Archives of general psychiatry.
[11] Christian Sander,et al. Chapter 4 – EEG Vigilance and Phenotypes in Neuropsychiatry: Implications for Intervention , 2011 .
[12] P. Fitzgerald,et al. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. , 2003, Archives of general psychiatry.
[13] B. Clemens,et al. Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings , 2006, Epilepsy Research.
[14] N. Garmezy. On some risks in risk research , 1977, Psychological Medicine.
[15] Leanne M Williams,et al. Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery. , 2006, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[16] P. Schoenknecht,et al. Treatment of Acute Mania with Modafinil Monotherapy , 2010, Biological Psychiatry.
[17] P. Fitzgerald,et al. Priming Stimulation Enhances the Effectiveness of Low-Frequency Right Prefrontal Cortex Transcranial Magnetic Stimulation in Major Depression , 2008, Journal of clinical psychopharmacology.
[18] E Donchin,et al. A new method for off-line removal of ocular artifact. , 1983, Electroencephalography and clinical neurophysiology.
[19] F. Quitkin,et al. Cognitive ERPs in Depressive and Anxiety Disorders during Tonal and Phonetic Oddball Tasks , 2002, Clinical EEG.
[20] R. Bagby,et al. Psychosocial and clinical predictors of response to pharmacotherapy for depression. , 2002, Journal of psychiatry & neuroscience : JPN.
[21] K. Hashimoto,et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants , 2003, Biological Psychiatry.
[22] Yoshihiko Koga,et al. Regional Cerebral Blood Flow Changes after Low-Frequency Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in Treatment-Resistant Depression , 2008, Neuropsychobiology.
[23] C. Tenke,et al. Brain event-related potentials to complex tones in depressed patients: relations to perceptual asymmetry and clinical features. , 1995, Psychophysiology.
[24] B N Gangadhar,et al. "Normal' P300 amplitude predicts rapid response to ECT in melancholia. , 1996, Journal of affective disorders.
[25] Y. Lapierre,et al. Quantitative EEG in the prediction of antidepressant response to imipramine. , 1996, Journal of affective disorders.
[26] M. Arns,et al. Potential differential effects of 9 Hz rTMS and 10 Hz rTMS in the treatment of depression , 2010, Brain Stimulation.
[27] S. Wisniewski,et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: Rationale and protocol , 2011 .
[28] E. Gordon,et al. An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. , 2011, Journal of affective disorders.
[29] G. Ulrich,et al. Quantitative assessment of dynamic electroencephalogram (EEG) organization as a tool for subtyping depressive syndromes , 1999, European Psychiatry.
[30] F. Angelucci,et al. BDNF in schizophrenia, depression and corresponding animal models , 2005, Molecular Psychiatry.
[31] D. Schutter. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis , 2008, Psychological Medicine.
[32] M. Kubo,et al. Dialysis-Related Hypotension as a Cause of Progressive Frontal Lobe Atrophy in Chronic Hemodialysis Patients: A 3-Year Prospective Study , 2004, Nephron Clinical Practice.
[33] Z. Nahas,et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. , 1999, The Journal of neuropsychiatry and clinical neurosciences.
[34] M. Arns,et al. EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder , 2010, Clinical Neurophysiology.
[35] S. Wisniewski,et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol , 2011, Trials.
[36] U. Hegerl,et al. Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? , 2010, Current opinion in psychiatry.
[37] K Frick,et al. Interrelation between Changes in the EEG and Psychopathology under Pharmacotherapy for Endogenous Depression , 1984, Pharmacopsychiatry.
[38] J. Markowitz,et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. , 2000, The New England journal of medicine.
[39] E. Gordon,et al. CROSS-CULTURAL ASSESSMENT OF NEUROPSYCHOLOGICAL PERFORMANCE AND ELECTRICAL BRAIN FUNCTION MEASURES: ADDITIONAL VALIDATION OF AN INTERNATIONAL BRAIN DATABASE , 2007, The International journal of neuroscience.
[40] Martijn Arns,et al. EEG phenotypes predict treatment outcome to stimulants in children with ADHD. , 2008, Journal of integrative neuroscience.
[41] A. Hunter,et al. Midline and right frontal brain function as a physiologic biomarker of remission in major depression , 2009, Psychiatry Research: Neuroimaging.
[42] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[43] Wolfgang Klimesch,et al. Individual differences in brain dynamics: important implications for the calculation of event-related band power , 1998, Biological Cybernetics.
[44] P. Fitzgerald,et al. A randomized trial of the anti‐depressant effects of low‐ and high‐frequency transcranial magnetic stimulation in treatment‐resistant depression , 2009, Depression and anxiety.
[45] S. Uijtdehaage,et al. Relationship between brain electrical activity and cortical perfusion in normal subjects , 1999, Psychiatry Research: Neuroimaging.
[46] Maurizio Fava,et al. Frontal EEG predictors of treatment outcome in major depressive disorder , 2009, European Neuropsychopharmacology.
[47] Sergio P. Rigonatti,et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. , 2006, The international journal of neuropsychopharmacology.
[48] T. Itil,et al. COMPUTERIZED EEC: PREDICTOR OF OUTCOME IN SCHIZOPHRENIA , 1975, The Journal of nervous and mental disease.
[49] N. Kathmann,et al. Positive predictors for antidepressive response to prefrontal repetitive transcranial magnetic stimulation (rTMS). , 2007, Journal of psychiatric research.
[50] H. Möller,et al. Response and remission criteria in major depression--a validation of current practice. , 2010, Journal of psychiatric research.
[51] 石井 良平. Medial prefrontal cortex generates frontal midline theta rhythm , 1999 .
[52] T. Bschor,et al. Decreased Level of EEG-Vigilance in Acute Mania as a Possible Predictor for a Rapid Effect of Methylphenidate: A Case Study , 2001, Clinical EEG.
[53] S C Suffin,et al. Neurometric Subgroups in Attentional and Affective Disorders and Their Association with Pharmacotherapeutic Outcome , 1995, Clinical EEG.
[54] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[55] Fernando Lopes da Silva,et al. Comprar Niedermeyer's Electroencephalography, 6/e (Basic Principles, Clinical Applications, and Related Fields ) | Fernando Lopes Da Silva | 9780781789424 | Lippincott Williams & Wilkins , 2010 .
[56] R. de Raedt,et al. HF-rTMS Treatment in Medication-Resistant Melancholic Depression: Results from 18FDG-PET Brain Imaging , 2009, CNS Spectrums.
[57] A. Walker. Electroencephalography, Basic Principles, Clinical Applications and Related Fields , 1982 .
[58] D. Schutter. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder , 2010, Psychological Medicine.
[59] P. Rossini,et al. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. , 2006, Journal of affective disorders.
[60] S. Kennedy,et al. Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome. , 2000, Pharmacopsychiatry.
[61] Gregory E Simon,et al. Personalized medicine for depression: can we match patients with treatments? , 2010, The American journal of psychiatry.
[62] H. Asada,et al. Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans , 1999, Neuroscience Letters.
[63] Jan K. Buitelaar,et al. The increase in theta/beta ratio on resting-state EEG in boys with attention-deficit/hyperactivity disorder is mediated by slow alpha peak frequency , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[64] M. Maes,et al. Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. , 1998, Journal of affective disorders.
[65] E. Gordon,et al. THE TEST-RETEST RELIABILITY OF A STANDARDIZED NEUROCOGNITIVE AND NEUROPHYSIOLOGICAL TEST BATTERY: “NEUROMARKER” , 2005, The International journal of neuroscience.
[66] Jen-Chuen Hsieh,et al. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. , 2010, Journal of affective disorders.
[67] J. Henry,et al. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. , 2005, The British journal of clinical psychology.
[68] P. Fitzgerald,et al. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression , 2010, Psychological Medicine.
[69] D. Pizzagalli. Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response , 2011, Neuropsychopharmacology.
[70] Adrian Preda,et al. The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. , 2011, Journal of psychiatric research.